Literature DB >> 16861349

Phospholipase D2 acts as an essential adaptor protein in the activation of Syk in antigen-stimulated mast cells.

Jun Ho Lee1, Young Mi Kim, Nam Wook Kim, Jie Wan Kim, Erk Her, Bo Kyung Kim, Jong Hyun Kim, Sung Ho Ryu, Jong Woo Park, Dong Wan Seo, Jeung Whan Han, Michael A Beaven, Wahn Soo Choi.   

Abstract

Mast cells are responsible for IgE-mediated allergic reactions. Phospholipase D1 (PLD1) and PLD2 regulate mast cell activation, but the mechanisms remain unclear. Here we show that PLD2 associates with and promotes activation of Syk, a key enzyme in mast cell activation. Antigen stimulation resulted in increased association and colocalization of Syk with PLD2 on the plasma membrane as indicated by coimmunoprecipitation and confocal microscopy. This association was dependent on tyrosine phosphorylation of Syk but not on PLD2 activity. In vitro, PLD2 interacted via its Phox homology (PX) domain with recombinant Syk to induce phosphorylation and activation of Syk. Furthermore, overexpression of PLD2 or catalytically inactive PLD2K758R enhanced antigen-induced phosphorylations of Syk and its downstream targets, the adaptor proteins LAT and SLP-76, while expression of a PLD2 siRNA blocked these phosphorylations. Apparently, the interaction of PLD2 with Syk is an early critical event in the activation of mast cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861349      PMCID: PMC1895856          DOI: 10.1182/blood-2005-10-009159

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  69 in total

Review 1.  Mammalian phospholipase D structure and regulation.

Authors:  M A Frohman; T C Sung; A J Morris
Journal:  Biochim Biophys Acta       Date:  1999-07-30

2.  Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.

Authors:  Jong Hyun Kim; Jung Hwan Kim; Motoi Ohba; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Phosphorylation and activation of phospholipase D1 by protein kinase C in vivo: determination of multiple phosphorylation sites.

Authors:  Y Kim; J M Han; J B Park; S D Lee; Y S Oh; C Chung; T G Lee; J H Kim; S K Park; J S Yoo; P G Suh; S H Ryu
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

4.  An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells.

Authors:  Ze Peng; Michael A Beaven
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

5.  Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase.

Authors:  Kyung D Moon; Carol B Post; Donald L Durden; Qing Zhou; Pradip De; Marietta L Harrison; Robert L Geahlen
Journal:  J Biol Chem       Date:  2004-11-09       Impact factor: 5.157

6.  Selective activation of phospholipase D2 by unsaturated fatty acid.

Authors:  J H Kim; Y Kim; S D Lee; I Lopez; R S Arnold; J D Lambeth; P G Suh; S H Ryu
Journal:  FEBS Lett       Date:  1999-07-02       Impact factor: 4.124

7.  The elucidation of novel SH2 binding sites on PLD2.

Authors:  M Di Fulvio; N Lehman; X Lin; I Lopez; J Gomez-Cambronero
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

8.  The uncovering of a novel regulatory mechanism for PLD2: formation of a ternary complex with protein tyrosine phosphatase PTP1B and growth factor receptor-bound protein GRB2.

Authors:  Jeff Horn; Isabel Lopez; Mill W Miller; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2005-06-24       Impact factor: 3.575

9.  SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells.

Authors:  V I Pivniouk; T R Martin; J M Lu-Kuo; H R Katz; H C Oettgen; R S Geha
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

10.  Distinct roles for the linker region tyrosines of Syk in FcepsilonRI signaling in primary mast cells.

Authors:  Maria Simon; Lesley Vanes; Robert L Geahlen; Victor L J Tybulewicz
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

View more
  9 in total

1.  Real-time cross-correlation image analysis of early events in IgE receptor signaling.

Authors:  Raibatak Das; Stephanie Hammond; David Holowka; Barbara Baird
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

2.  Antimicrobial agent triclosan suppresses mast cell signaling via phospholipase D inhibition.

Authors:  Juyoung K Shim; Molly A Caron; Lisa M Weatherly; Logan B Gerchman; Suraj Sangroula; Siham Hattab; Alan Y Baez; Talya J Briana; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2019-08-19       Impact factor: 3.446

Review 3.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

4.  Differential Roles of Phospholipase D Proteins in FcεRI-Mediated Signaling and Mast Cell Function.

Authors:  Minghua Zhu; Jianwei Zou; Tieshi Li; Sarah A O'Brien; Yao Zhang; Sarah Ogden; Weiguo Zhang
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

5.  Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice.

Authors:  Kinuko Ohneda; Takashi Moriguchi; Shin'ya Ohmori; Yasushi Ishijima; Hironori Satoh; Sjaak Philipsen; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

6.  Phospholipase d promotes lipid microdomain-associated signaling events in mast cells.

Authors:  Felipe A Lisboa; Ze Peng; Christian A Combs; Michael A Beaven
Journal:  J Immunol       Date:  2009-09-30       Impact factor: 5.422

7.  Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells.

Authors:  Manpreet S Chahal; Daniel J Brauner; Kathryn E Meier
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-02

Review 8.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

9.  An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.

Authors:  Young Hwan Park; Hyun Woo Kim; Hyuk Soon Kim; Seung Taek Nam; Dajeong Lee; Min Bum Lee; Keun Young Min; Jimo Koo; Su Jeong Kim; Young Mi Kim; Hyung Sik Kim; Wahn Soo Choi
Journal:  Biomol Ther (Seoul)       Date:  2019-05-01       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.